CCIWA Call (888) 217-1376 24/7 confidential

Suboxone Treatment Providers in Missoula, Montana

11 clinicians with active NPPES enumerations in Missoula list specialties that commonly prescribe buprenorphine for opioid use disorder. The Consolidated Appropriations Act of 2023 removed the X-waiver requirement. Any DEA Schedule II to V prescriber may now legally prescribe Suboxone, Subutex, Sublocade, or Zubsolv. Whether they actively take new MOUD patients is a separate question. You have to ask on the phone.

Missoula, Montana

11 providers in Missoula

How to use this list. Call before showing up. Ask three things: do you accept new buprenorphine patients, do you take my insurance, and what is your earliest induction appointment. Most clinics that move fast can induct within a week. If a clinic delays past two weeks, keep calling other listings.

Missoula at a glance

75,600
Residents
35 sq mi
Land area
34.3
Median age
$65,329
Median household income
6.2%
Uninsured (civilian)
6.1%
Families below poverty

Source: U.S. Census Bureau, ACS 5-year estimates (2023).

Overdose context for Missoula County

Missoula County reported a model-based drug poisoning death rate of 28.5 per 100,000 residents in 2021 (95% CI 25.5 to 31.8). That matches the national county mean of 28.5 per 100,000.

201919
202024.7
202128.5

Three-year change (19 to 28.5): +9.4 per 100,000.

County-level estimates are reported at the county level, not the city level. Source: NCHS Drug Poisoning Mortality by County (CDC dataset rpvx-m2md), 2019 to 2021 model-based estimates. NCHS urban/rural classification: Micropolitan.

What this means for accessing buprenorphine here

Missoula County reports a 2021 drug poisoning death rate of 28.5 per 100,000, slightly above the national county mean of 28.5. Uninsured rate sits at 6.2%. Most prescribers in the area bill commercial insurance and at least one Medicaid plan. Ask which. Missoula has roughly 75,600 residents. The provider list below maps to that population, not to the broader county.

Suboxone vs methadone for opioid use disorder

Suboxone is buprenorphine plus naloxone. It binds tightly to opioid receptors but only partially activates them. That partial-agonist behavior is why it has a ceiling on respiratory depression and a much lower overdose risk than methadone. It is also why it is delivered through office visits and prescriptions instead of daily clinic dosing.

Methadone is a full agonist. It is more powerful for severe long-term opioid use disorder, especially fentanyl-driven cases. The trade-off is that methadone is only legally dispensed through SAMHSA-certified opioid treatment programs, which means daily dosing visits, at least at the start.

If you are in Missoula weighing the two, the decision usually comes down to severity, history of treatment, and your daily logistics. Buprenorphine is easier to access. Methadone is sometimes the better clinical fit.

Need daily-dose methadone instead? See methadone clinics in Missoula.

Want a non-opioid alternative? See Montana Vivitrol providers for monthly extended-release naltrexone.

State-level scoring, regulatory context, and full provider directory live on the Montana Suboxone hub.